why choose us

First received: February 02, 2024

Clinical Trial: A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Gastro-enteropancreatic Neuroendocrine Tumor

Study Type: OBSERVATIONAL


Official Title: BackSOM Study: Qualitative Study in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly

Brief Summary: Participants of this study are adults with GEP-NETs and/or acromegaly who were using the Ipsen lanreotide syringe and have transitioned in the last 6 months to the Pharmathen lanreotide syringe, having received at least two injections using the Pharmathen syringe.GEP-NETs are abnormal growths that develop in the digestive system, including the stomach, intestines, and pancreas.These tumors arise from special cells called neuroendocrine cells, which are found in these organs and release hormones to regulate…

Read more